Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Brent L. Larson currently holds 222,237 shares of NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Brent L. Larson has been a net seller of NAVB stock. They have purchased $8.2K and sold $316.3K worth of shares.
Brent L. Larson's most recent insider trade was on Dec 1, 2015, when they sold 12,500 shares at $1.50 per share.
Brent L. Larson serves as Executive at NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB). They have executed 31 insider transactions totaling $324.5K over their tenure at the company.
Brent L. Larson holds the position of Executive at NAVIDEA BIOPHARMACEUTICALS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Brent L. Larson has shown a selling trading pattern, with $8.2K in total purchases and $316.3K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Brent L. Larson was on Mar 13, 2013, when they sold $135.3K worth of NAVB shares. This transaction involved 42,821 shares at $3.16 per share.
Brent L. Larson currently owns 222,237 shares of NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Brent L. Larson's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Brent L. Larson has 31 Form 4 filings on record as an insider at NAVIDEA BIOPHARMACEUTICALS, INC..
Set alerts for Brent L. Larson and 40,000+ other insiders.